Omega Therapeutics, Inc. reported positive early findings from the first two doses of its Phase 1/2 MYCHELANGELO™ I study on OTX-2002. The study focuses on hepatocellular carcinoma patients and others with solid tumors linked to the c-MYC gene.

This article summarized the latest R&D progress of Cinnarizine, the Mechanism of Action for Cinnarizine, and the drug target R&D trends for Cinnarizine.

SOS1, is a protein that plays a crucial role in signal transduction pathways within the human body.

Immunovant, Inc. recently revealed preliminary results of a Phase 1 clinical trial for IMVT-1402.

This article summarized the latest R&D progress of Carfilzomib, the Mechanism of Action for Carfilzomib, and the drug target R&D trends for Carfilzomib.

Nippon Kayaku Co., Ltd. and Celltrion Healthcare Japan K.K. have gained approval to manufacture and sell various Adalimumab BS Subcutaneous Injections and Pens in Japan.

RET is a proto-oncogene initially discovered in 1985, it is located on chromosome 10q11.2, encoding a transmembrane glycoprotein: receptor tyrosine kinase.

This article summarized the latest R&D progress of Cangrelor, the Mechanism of Action for Cangrelor, and the drug target R&D trends for Cangrelor.

AcuraStem proclaimed it has signed a licensing deal with Takeda.

This article summarized the latest R&D progress of Calcifediol, the Mechanism of Action for Calcifediol, and the drug target R&D trends for Calcifediol.

SGLT1, or sodium-glucose co-transporter 1, plays a crucial role in the human body by facilitating the absorption of glucose and galactose in the small intestine.

This article summarized the latest R&D progress of Folinic acid, the Mechanism of Action for Folinic acid, and the drug target R&D trends for Folinic acid.